BRIEF published on 07/01/2026 at 17:50, 6 days 15 hours ago Unlimited renewal of the marketing authorization for Sibnayal® by Advicenne in the United Kingdom United Kingdom Advicenna Sibnayal Rare Kidney Diseases Marketing Authorization Renewal
BRIEF published on 06/22/2026 at 19:12, 15 days 13 hours ago Advicenne Secures Financing to Q2 2027 with New Bond Issue Strategic Development Bond Financing FDA Registration Advicenne Rare Kidney Diseases
PRESS RELEASE published on 06/22/2026 at 19:07, 15 days 14 hours ago Inside Information / Other news releases Advicenne secures €3.8 million bond financing, extending cash runway to Q2 2027, for FDA registration of ADV7103 in the USA Bond Financing FDA Registration Advicenne Cash Runway ADV7103
BRIEF published on 06/01/2026 at 07:50, 1 month 7 days ago Advicenne receives reimbursement for Likozam® and reduces its debt Advicenna Refund Likozam Debt Reduced Discounts Early Access
BRIEF published on 05/21/2026 at 21:07, 1 month 17 days ago Advicenne: Evolution of governance and challenges ahead Governance Pharmaceutical Restructuring Advicenna Sibnayal®
BRIEF published on 05/21/2026 at 21:07, 1 month 17 days ago Advicenne Announces Governance Changes Post-AGM Annual General Meeting Financial Restructuring Board Appointments Governance Changes Advicenne
PRESS RELEASE published on 05/21/2026 at 21:02, 1 month 17 days ago Inside Information / Other news releases Advicenne announces governance changes post Annual General Meeting 2026 including appointment of new directors and committee chairs, adapting structure to support U.S. marketing and financial restructuring Annual General Meeting Directors Governance Changes Advicenne Committee Chairs
BRIEF published on 05/05/2026 at 22:12, 2 months 2 days ago Advicenne Initiates Safeguard Proceedings to Restructure Debt Debt Restructuring Advicenne Pharmaceutical Sector Safeguard Proceedings Sibnayal®
PRESS RELEASE published on 05/05/2026 at 22:07, 2 months 2 days ago Inside Information / Other news releases Advicenne initiates safeguard proceedings to restructure debt and extend cash runway, granted by Paris Commercial Court. Proactive financial restructuring to ensure continuity Paris Commercial Court Advicenne Cash Runway Restructure Safeguard Proceedings
BRIEF published on 03/26/2026 at 20:14, 3 months 12 days ago Advicenne's 2025 Financial Overview: Mixed Results and Future Prospects Revenue Growth FDA Approval Advicenne Financial Results 2025 Sibnayal®
Published on 07/08/2026 at 08:00, 1 hour 7 minutes ago Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 07/08/2026 at 03:25, 5 hours 42 minutes ago Linear Provides Update on Proposed Acquisition of Critical Prospecting Corp
Published on 07/08/2026 at 01:10, 7 hours 57 minutes ago Galantas Announces Resignation of Chair of the Board
Published on 07/07/2026 at 23:15, 9 hours 52 minutes ago Guanajuato Silver Announces Officer Resignation
Published on 07/07/2026 at 22:15, 10 hours 52 minutes ago Grande Portage Closes C$6 Million Equity Financing
Published on 07/08/2026 at 08:38, 28 minutes ago innoscripta SE Accelerates Regional Expansion with New Hamburg Office
Published on 07/08/2026 at 08:30, 37 minutes ago Energiekontor AG: Energiekontor successfully commissions sold Drensteinfurt-Rieth wind park and obtains further building permits
Published on 07/08/2026 at 07:53, 1 hour 14 minutes ago Einhell continues growth trajectory – strong signal at the 2026 Annual General Meeting
Published on 07/07/2026 at 18:10, 14 hours 57 minutes ago LNA Santé and Euryale join forces to expand hospitalisation at home services across healthcare regions
Published on 07/07/2026 at 18:05, 15 hours 2 minutes ago Covivio - Half-yearly report on the liquidity contract on 30 June 2026
Published on 07/07/2026 at 18:01, 15 hours 6 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 07/07/2026 at 18:00, 15 hours 7 minutes ago Share Buyback Offer (OPRA) favored to implement shareholder return following the sale of Novacel
